EUR/JPY clings to modest daily gains, bulls await a sustained move beyond 118.00 mark
|- EUR/JPY regains some traction on Wednesday, albeit struggled to find acceptance above 118.00.
- Doubts about a potential COVID-19 vaccine benefitted the safe-haven JPY and capped the upside.
- The headline Eurozone CPI missed flash estimates and also did little to provide any fresh impetus.
The EUR/JPY cross held on to its modest daily gains near the 117.80 and had a rather muted reaction to the final Eurozone CPI report.
Following the previous day's intraday pullback from five-week tops, the cross managed to regain some positive traction on Wednesday. The uptick, however, lacked any strong follow-through and the EUR/JPY cross continued with its struggle to find acceptance above the 118.00 round-figure mark.
The shared currency remained well supported by the Franco-German proposal for a €500 billion European recovery fund. Bulls seemed rather unaffected by Wednesday release of softer-than-expected final Eurozone CPI, which missed the flash estimate and came in at 0.3% for April.
Meanwhile, doubts on a potential vaccine for the deadly virus benefitted the Japanese yen's perceived safe-haven status and capped the upside for the EUR/JPY cross. Reports on Tuesday indicated that the US drugmaker Moderna had provided insufficient data to determine the vaccine’s efficacy.
The negative factor, to a larger extent, was negated by a strong rally in the US equity futures. This coupled with speculations that the Bank of Japan might introduce extraordinary easing measures at an unscheduled meeting on Friday remained supportive of a mildly bid tone surrounding the cross.
However, it will be prudent to wait for a sustained move beyond the 118.00 mark before positioning for any further near-term appreciating move. Above the mentioned level, bulls might aim to test the 118.50 supply zone before eventually darting towards reclaiming the 119.00 mark.
Technical levels to watch
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.